Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

1.

A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy.

McDougle CJ, Price LH, Goodman WK, Charney DS, Heninger GR.

J Clin Psychopharmacol. 1991 Jun;11(3):175-84.

PMID:
1820757
[PubMed - indexed for MEDLINE]
2.

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.

Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF.

Mol Psychiatry. 2006 Jul;11(7):622-32. Epub 2006 Apr 4. Review. Erratum in: Mol Psychiatry. 2006 Aug;11(8):795.

PMID:
16585942
[PubMed - indexed for MEDLINE]
3.

New pharmacologic approaches to obsessive compulsive disorder.

Insel TR.

J Clin Psychiatry. 1990 Oct;51 Suppl:47-51; discussion 56-8. Review.

PMID:
2120204
[PubMed - indexed for MEDLINE]
4.

[Efficacy of antipsychotic augmentation therapy in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomised, placebo-controlled trials].

Dold M, Aigner M, Lanzenberger R, Kasper S.

Fortschr Neurol Psychiatr. 2011 Aug;79(8):453-66. doi: 10.1055/s-0031-1273397. Epub 2011 Aug 1. Review. German.

PMID:
21809258
[PubMed - indexed for MEDLINE]
5.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
[PubMed - indexed for MEDLINE]
6.

Biological approaches to treatment-resistant obsessive compulsive disorder.

Goodman WK, McDougle CJ, Barr LC, Aronson SC, Price LH.

J Clin Psychiatry. 1993 Jun;54 Suppl:16-26. Review.

PMID:
8331098
[PubMed - indexed for MEDLINE]
7.

A review of pharmacologic treatments for obsessive-compulsive disorder.

Kaplan A, Hollander E.

Psychiatr Serv. 2003 Aug;54(8):1111-8. Review.

PMID:
12883138
[PubMed - indexed for MEDLINE]
8.

Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions.

Goodman WK, Ward H, Kablinger A, Murphy T.

J Clin Psychiatry. 1997;58 Suppl 5:32-49. Review.

PMID:
9184625
[PubMed - indexed for MEDLINE]
9.

Pharmacotherapy of obsessive compulsive disorder.

Goodman WK, McDougle CJ, Price LH.

J Clin Psychiatry. 1992 Apr;53 Suppl:29-37. Review.

PMID:
1532962
[PubMed - indexed for MEDLINE]
10.

Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder.

Fineberg NA, Bullock T, Montgomery DB, Montgomery SA.

Int Clin Psychopharmacol. 1992 Jun;7 Suppl 1:43-7. Review. No abstract available.

PMID:
1517558
[PubMed - indexed for MEDLINE]
11.

A review of fluvoxamine and its uses in depression.

Burton SW.

Int Clin Psychopharmacol. 1991 Dec;6 Suppl 3:1-17; discussion 17-21. Review.

PMID:
1806631
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk